Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?
Mangana, Joanna, Cheng, Phil F., Schindler, Katja, Weide, Benjamin, Held, Ulrike, Frauchiger, Anna L., Romano, Emanuella, Kähler, Katharina C., Rozati, Sima, Rechsteiner, Markus, Moch, Holger, MichielVolume:
10
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0139438
Date:
October, 2015
File:
PDF, 451 KB
english, 2015